A Multicentric Experience on Living Donor Liver Transplantation in COVID-19 Hotspots in India.

As of August 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 213 countries, leading to more than 18 million cases and 690,000 deaths. India is the second most affected country, with the majority of cases in metropolitan cities, such as Mumbai, New Delhi, Chennai, and Bengaluru. There is limited literature on the outcomes and safety of performing living donor liver transplantation (LDLT) in coronavirus disease 2019 (COVID-19) epicenters.